Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.96 USD | +0.22% | +9.65% | +143.13% |
Mar. 14 | VTv Therapeutics Inc. Announces Board Changes | CI |
Mar. 13 | VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | 2.02M | Sales 2023 | - | Capitalization | 23.43M |
---|---|---|---|---|---|
Net income 2022 | -19M | Net income 2023 | -20M | EV / Sales 2022 | 21.1 x |
Net cash position 2022 | 11.42M | Net cash position 2023 | 8.98M | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.59
x | P/E ratio 2023 |
-1.18
x | Employees | 16 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.45% |
1 day | -0.99% | ||
1 week | +11.71% | ||
1 month | +18.57% | ||
3 months | +231.75% | ||
6 months | +67.27% | ||
Current year | +142.61% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CEO | Chief Executive Officer | 66 | 22-07-31 |
Steven Tuch
DFI | Director of Finance/CFO | 56 | 22-12-07 |
Vanessa McDade
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | Feb. 26 | |
Paul Sekhri
CEO | Chief Executive Officer | 66 | 22-07-31 |
Richard Nelson
BRD | Director/Board Member | 54 | 20-11-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 27.96 | +0.22% | 3 885 |
24-04-30 | 27.9 | -0.99% | 6,376 |
24-04-29 | 28.18 | +4.51% | 4,173 |
24-04-26 | 26.96 | +4.64% | 3,777 |
24-04-25 | 25.77 | +1.06% | 1,576 |
Delayed Quote Nasdaq, April 30, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+142.61% | 67.88M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.21% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- VTVT Stock